Munger Mode rating: 4 out of 5 — Buy. Our own rating from the research report below, on business quality first: moat durability and management, with price separating the top three.
We have tried to apply one test: would we be comfortable owning this business through a decade we cannot predict? CME passes more easily than almost any company we know. Moat. CME holds a near-monopoly in the most liquid U.S. futures. Interest rates, equity indexes, energy, grains and metals all trade there, and the liquidity keeps the position self-reinforcing. The clearing house adds a second lock, because open positions cannot move to a rival. Business quality. The Q3 operating margin was 65.7%. Capital spending is trivial, free cash flow roughly equals net income, and growth needs almost no reinvestment. Price. Our intrinsic value range is roughly $240 to $345, with a central estimate near $285 to $295. At about $296 we are paying fair value for a wonderful business. That is a 4, not a 5. The qualification we owe you.
Recent filings analysed: 10-Q (2026-10-23), 8-K (2026-10-21), 8-K (2026-08-11), 10-Q (2026-07-24).
Stock screener · Superinvestor 13F holdings · Analyst sentiment